Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death

Kan Liu, Andrew J. Paterson, Edward Chin, Jeffrey E. Kudlow

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

The pancreatic β cell can respond in the long term to hyperglycemia both with an increased capacity for insulin production and, in susceptible individuals, with apoptosis. When glucose-induced apoptosis offsets the increasing β cell capacity, type 2 diabetes results. Here, we tested the idea that the pathway of glucose metabolism that leads to the modification of intracellular proteins with the O-linked monosaccharide N-acetylglucosamine (O-Glc-NAc) is involved in the glucose-induced apoptosis. This idea is based on two recent observations. First, the β cell expresses much more O-GlcNAc transferase than any other known cell, and second, that the β cell-specific toxin, streptozotocin (STZ), itself a GlcNAc analog, specifically blocks the enzyme that cleaves O-GlcNAc from intracellular proteins. As a consequence, we now show that hyperglycemia leads to the rapid and reversible accumulation of O-GlcNAc specifically in β cells in vivo. Animals pretreated with STZ also accumulate O-GlcNAc in their β cells when hyperglycemic, but this change is sustained upon re-establishment of euglycemia. In concert with the idea that STZ toxicity results from the sustained accumulation of O-GlcNAc after a hyperglycemic episode, we established a low-dose STZ protocol in which the β cells' toxicity of STZ was manifest only after glucose or glucosamine administration. Transgenic mice with impaired β cell glucosamine synthesis treated with this protocol are resistant to the diabetogenic effect of STZ plus glucose yet succumb to STZ plus glucosamine. This study provides a causal link between apoptosis in β cells and glucose metabolism through glucosamine to O-GlcNAc, implicating this pathway of glucose metabolism with β cell glucose toxicity.

Original languageEnglish (US)
Pages (from-to)2820-2825
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number6
StatePublished - Mar 14 2000

Fingerprint

Cell Death
Streptozocin
Glucose
Glucosamine
Proteins
Apoptosis
Hyperglycemia
Acetylglucosamine
Monosaccharides
Type 2 Diabetes Mellitus
Transgenic Mice
Insulin
Enzymes

ASJC Scopus subject areas

  • General

Cite this

Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells : Linkage of O-linked GlcNAc to β cell death. / Liu, Kan; Paterson, Andrew J.; Chin, Edward; Kudlow, Jeffrey E.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 6, 14.03.2000, p. 2820-2825.

Research output: Contribution to journalArticle

@article{7f2507ce059344a08f85c376a6e78025,
title = "Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death",
abstract = "The pancreatic β cell can respond in the long term to hyperglycemia both with an increased capacity for insulin production and, in susceptible individuals, with apoptosis. When glucose-induced apoptosis offsets the increasing β cell capacity, type 2 diabetes results. Here, we tested the idea that the pathway of glucose metabolism that leads to the modification of intracellular proteins with the O-linked monosaccharide N-acetylglucosamine (O-Glc-NAc) is involved in the glucose-induced apoptosis. This idea is based on two recent observations. First, the β cell expresses much more O-GlcNAc transferase than any other known cell, and second, that the β cell-specific toxin, streptozotocin (STZ), itself a GlcNAc analog, specifically blocks the enzyme that cleaves O-GlcNAc from intracellular proteins. As a consequence, we now show that hyperglycemia leads to the rapid and reversible accumulation of O-GlcNAc specifically in β cells in vivo. Animals pretreated with STZ also accumulate O-GlcNAc in their β cells when hyperglycemic, but this change is sustained upon re-establishment of euglycemia. In concert with the idea that STZ toxicity results from the sustained accumulation of O-GlcNAc after a hyperglycemic episode, we established a low-dose STZ protocol in which the β cells' toxicity of STZ was manifest only after glucose or glucosamine administration. Transgenic mice with impaired β cell glucosamine synthesis treated with this protocol are resistant to the diabetogenic effect of STZ plus glucose yet succumb to STZ plus glucosamine. This study provides a causal link between apoptosis in β cells and glucose metabolism through glucosamine to O-GlcNAc, implicating this pathway of glucose metabolism with β cell glucose toxicity.",
author = "Kan Liu and Paterson, {Andrew J.} and Edward Chin and Kudlow, {Jeffrey E.}",
year = "2000",
month = "3",
day = "14",
language = "English (US)",
volume = "97",
pages = "2820--2825",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "6",

}

TY - JOUR

T1 - Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells

T2 - Linkage of O-linked GlcNAc to β cell death

AU - Liu, Kan

AU - Paterson, Andrew J.

AU - Chin, Edward

AU - Kudlow, Jeffrey E.

PY - 2000/3/14

Y1 - 2000/3/14

N2 - The pancreatic β cell can respond in the long term to hyperglycemia both with an increased capacity for insulin production and, in susceptible individuals, with apoptosis. When glucose-induced apoptosis offsets the increasing β cell capacity, type 2 diabetes results. Here, we tested the idea that the pathway of glucose metabolism that leads to the modification of intracellular proteins with the O-linked monosaccharide N-acetylglucosamine (O-Glc-NAc) is involved in the glucose-induced apoptosis. This idea is based on two recent observations. First, the β cell expresses much more O-GlcNAc transferase than any other known cell, and second, that the β cell-specific toxin, streptozotocin (STZ), itself a GlcNAc analog, specifically blocks the enzyme that cleaves O-GlcNAc from intracellular proteins. As a consequence, we now show that hyperglycemia leads to the rapid and reversible accumulation of O-GlcNAc specifically in β cells in vivo. Animals pretreated with STZ also accumulate O-GlcNAc in their β cells when hyperglycemic, but this change is sustained upon re-establishment of euglycemia. In concert with the idea that STZ toxicity results from the sustained accumulation of O-GlcNAc after a hyperglycemic episode, we established a low-dose STZ protocol in which the β cells' toxicity of STZ was manifest only after glucose or glucosamine administration. Transgenic mice with impaired β cell glucosamine synthesis treated with this protocol are resistant to the diabetogenic effect of STZ plus glucose yet succumb to STZ plus glucosamine. This study provides a causal link between apoptosis in β cells and glucose metabolism through glucosamine to O-GlcNAc, implicating this pathway of glucose metabolism with β cell glucose toxicity.

AB - The pancreatic β cell can respond in the long term to hyperglycemia both with an increased capacity for insulin production and, in susceptible individuals, with apoptosis. When glucose-induced apoptosis offsets the increasing β cell capacity, type 2 diabetes results. Here, we tested the idea that the pathway of glucose metabolism that leads to the modification of intracellular proteins with the O-linked monosaccharide N-acetylglucosamine (O-Glc-NAc) is involved in the glucose-induced apoptosis. This idea is based on two recent observations. First, the β cell expresses much more O-GlcNAc transferase than any other known cell, and second, that the β cell-specific toxin, streptozotocin (STZ), itself a GlcNAc analog, specifically blocks the enzyme that cleaves O-GlcNAc from intracellular proteins. As a consequence, we now show that hyperglycemia leads to the rapid and reversible accumulation of O-GlcNAc specifically in β cells in vivo. Animals pretreated with STZ also accumulate O-GlcNAc in their β cells when hyperglycemic, but this change is sustained upon re-establishment of euglycemia. In concert with the idea that STZ toxicity results from the sustained accumulation of O-GlcNAc after a hyperglycemic episode, we established a low-dose STZ protocol in which the β cells' toxicity of STZ was manifest only after glucose or glucosamine administration. Transgenic mice with impaired β cell glucosamine synthesis treated with this protocol are resistant to the diabetogenic effect of STZ plus glucose yet succumb to STZ plus glucosamine. This study provides a causal link between apoptosis in β cells and glucose metabolism through glucosamine to O-GlcNAc, implicating this pathway of glucose metabolism with β cell glucose toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0034646330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034646330&partnerID=8YFLogxK

M3 - Article

C2 - 10717000

AN - SCOPUS:0034646330

VL - 97

SP - 2820

EP - 2825

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 6

ER -